Financial Instruments Financial Instruments, Securities Received as Consideration (Details) - USD ($) $ in Thousands	9 Months Ended
Mar. 28, 2020	Mar. 30, 2019	Jun. 29, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Document Period End Date	Mar. 28, 2020
Proceeds from sale of shares	$ 0	$ 30,192
Estimated Fair Value			$ 140,990

The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585

Name:	us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration